0009-0001-6484-1365 Employment
-
Eli Lilly and Company Sr.Director Clinical Research2020 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET Save
- Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus Save
- Real-World Observational Study of Incidence and Outcomes in an HR+/HER2– Early Breast Cancer Population with High-Risk of Recurrence in Finland Save
- Real-world clinical profile, RET mutation testing, treatments, and PROs for MTC in Europe Save
- Durability of response with selpercatinib in patients with RET-activated Thyroid Cancer: Long-term Safety and Efficacy from LIBRETTO-001 Save
- High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway Save
- Continuation of Selpercatinib Beyond Progression in RET-mutant MTC: Data from LIBRETTO-001 Study Save
- Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer Save
- Estimating the incidence and characteristics of female patients in Norway with early breast cancer who are at high risk of disease recurrence Save
- A national precision cancer medicine implementation initiative for Norway Save